Latest Drugwonks' Blog

Foreign Affairs

As an antidote to the American media’s near-myopia about health care in considering the UK and Canada the only foreign countries with any relevance (which has abated somewhat but not nearly enough), some health care headlines from elsewhere in the world.

In Germany, in new poll by the Allensbach Institute indicates that the population is concerned about two-class medicine, with 72 percent of participants saying they are concerned that patients with private insurance get better treatment than those in the public system. And 80 percent of doctors say they don’t have enough time with patients to complete everything they need to.

Further, public sickness funds face deficits next year that are estimated at between 7 and 11 billion euros. Special “ancillary premiums” are likely to be charged by the sickness funds at some point this year and the insurers are seeking, unsuccessfully so far, more money from the government.

In France, the coffers of the national health care system are 9.4 billion euros in the red and conservative politicians there have been making ominous pronouncements about the future of the Sécurité Sociale system as a whole.

In Switzerland, health care premiums could rise up to 20 percent next year. A poll found that some 30 percent of people there may switch insurance companies if premiums go up 10 percent, some 43 percent if they increase 15 percent, and a majority will move to a cheaper company if the rise is indeed 20 percent. In addition, 58 percent say they are against the 30 Swiss franc (~$27) co-pay for visits to the doctor.

Deficits, co-pays, and too short consultations with the doctor. If this all sounds familiar, it should. The US isn’t alone in its problems and no system is perfect, all make trade-off with regard to what they cover and what they cost. All three of the above systems are either private or public-private hybrids that bear lots of similarities to the US system –and to American reform proposals, making it clear that no matter what the outcome of the bills now before Congress, the challenges the US faces aren’t going to magically melt away.

There are no panaceas in either policy or medicine and those who believe there are have been duped. The lesson is clear: look before you leap –and look carefully.

Word today is that Dan Schultz is leaving his post as CDRH director and retiring from the FDA.

That's a loss.

Dan's smart, feisty, and calls it like he sees it -- a trait that has often put him at odds with lesser mortals.

And he's a nice, decent guy. Two traits often in short supply.

Good luck and God's Speed Dan Schultz.

Lovenox Labors Lost

  • 08.12.2009
A few years ago I met Israel Markov, the "Big Abba" of Teva.  A memorable guy for a lot of reasons.  One of those reasons was his blunt Sabra honesty.  One thing he said to me was that "Teva isn't in the pharmaceutical business.  We are in the litigtation business."

It seems now that another company, Amphastar Pharmaceuticals, isn't satisfied with patent litigation as its weapon of choice.  Unsatisfied with the way the FDA is dealing with their file for generic Lovenox, they've achieved new lows by attempting personal intimidation tactics.  It won't work.

They're slinging mud.  It will only come back to splatter on their own reputation.  

Amphastar claims that its rival, Momenta,  has a "leg up" and is getting "special access."  And yet both companies are in the same place in the regulatory process and both companies are being asked for the same data sets.  And this is unfair why?

According to Amphastar it's unfair because CDER Director, Dr. Janet Woodcock co-authored a paper with one of Momenta's founders, MIT biological engineering professor Ram Sasisekharan, on how the FDA taskforce (on which they both served) identified and contained the cause of contaminated Chinese heparin imports.

Talk about desperate measures.

 Just so you know... From the latest AP editorial on heatlhcare

"His approval ratings slipping, President Barack Obama is retooling his message on health care overhaul, aiming to win over Americans who already have insurance."

Wait a minute.  I thought the goal of reform was to cover people who did not have insurance and couldn't afford it or were denied coverage.  Shouldn't the proposal be retooled as opposed to the message?

"Republicans say the heated debate is a sign of widespread public dissatisfaction with Obama's ideas. But with some of the anxieties spilling into angry disruptions and even threats, Democrats have accused Republicans of orchestrating the events to sabotage legislation. In an article published Monday, House Speaker Nancy Pelosi and Majority Leader Steny Hoyer wrote, "Drowning out opposing views is simply un-American."

Obama and his aides stayed away from such provocative language"

Right, they just set up a government website to collect information about political opposition and promising congressional Democrats that they would "punch back twice as hard" against opponents.  http://www.politico.com/news/stories/0809/25891.html

Do they address the major flaws and impact of every proposal on the table.

No.

Deal or No Deal?

  • 08.11.2009

Last night CBS News reported, "When he was running for President, Barack Obama attacked pharmaceutical companies for charging too much for prescription drugs. But now he's teamed up with those same companies to promote his healthcare plan," and critics are accusing President Obama "of making a back-room deal that could end up costing seniors plenty." CBS added, "Initial reports said the White House agreed not to seek price controls on drugs for seniors on Medicare and would not support importing cheaper drugs from Canada. Both the White House and the pharmaceutical industry now dispute that." CBS also noted that news of the "back-room deal riled fellow Democrats."

So, no deal?

But on August 5th, the New York Times ran a front page article headlined,


"White House Affirms Deal on Drug Cost
.”

It read in part,
Mr. Tauzin said the White House had tracked the negotiations throughout, assenting to decisions to move away from ideas like the government negotiation of prices or the importation of cheaper drugs from Canada. The $80 billion in savings would be over a 10-year period. “80 billion is the max, no more or less,” he said. “Adding other stuff changes the deal.” After reaching an agreement with Mr. Baucus, Mr. Tauzin said, he met twice at the White House with Rahm Emanuel, the White House chief of staff; Mr. Messina, his deputy; and Nancy-Ann DeParle, the aide overseeing the health care overhaul, to confirm the administration’s support for the terms. “They blessed the deal,” Mr. Tauzin said. Speaker Nancy Pelosi said the House was not bound by any industry deals with the Senate or the White House. But, Mr. Tauzin said, “as far we are concerned, that is a done deal.”

So, deal?

Simple yes-or-no question:  Does the President support "the deal" or does he not?

 

http://blogs.usatoday.com/oped/2009/08/unamerican-attacks-cant-derail-health-care-debate-.html

We have taken great pains to distance ourselves -- and those individuals who have attended town hall meetings of their own volition -- from the handful of individuals and one or two nut jobs who sought to shout rather than ask tough questions even as certain poitical operatives have sought to lump us, them and all into one seething hateful mob.

That is politics as usual.

But the editorial today by Speaker Pelosi and House Majority Leader Hoyer -- mostly unmentioned by the same media who covered the handful of angry Americans as if they were the vanguard of some neo-Bund movement -- calling those who assemble and organize against a misguided effort to increase government control over healthcare as "unAmerican.

Here is the key quote:

"An ugly campaign is underway not merely to misrepresent the health insurance reform legislation, but to disrupt public meetings and prevent members of Congress and constituents from conducting a civil dialogue. These tactics have included hanging in effigy one Democratic member of Congress in Maryland and protesters holding a sign displaying a tombstone with the name of another congressman in Texas, where protesters also shouted "Just say no!" drowning out those who wanted to hold a substantive discussion.

Let the facts be heard

These disruptions are occurring because opponents are afraid not just of differing views — but of the facts themselves. Drowning out opposing views is simply un-American. Drowning out the facts is how we failed at this task for decades."

Those who oppose or criticize are part of an ugly campaign to drown out opposing views and suppress the facts.   Thus we are unAmerican. 

Have you been or are you now part of any campaign to oppose health care reform.  If so, you are drowning out the facts.  And if you were oppose health care reform you obviously endorse hanging opponents in effigy.

I think the exchange between Joseph McCarthy and Joseph Welch sums up the tactics and desperate moral compass of Ms. Pelosi and Mr. Hoyer with respect to enacting single payer healthcare reform. I can't generalize to anyone else ...

http://en.wikipedia.org/wiki/Joseph_N._Welch

On June 9, 1954, the 30th day of the hearings, McCarthy accused Fred Fisher, one of the junior attorneys at Welch's firm, of association (while in law school) with the National Lawyers Guild (NLG), a group which J. Edgar Hoover sought to have the U.S. Attorney General designate as a Communist front organization (see Army-McCarthy hearings). Welch wrote off Fisher's association with the NLG as a youthful indiscretion and went after McCarthy for dragging the young man's name before a nationwide television audience with no prior warning or previous agreement to do so:

"Until this moment, Senator, I think I have never really gauged your cruelty or your recklessness. Fred Fisher is a young man who went to the Harvard Law School and came into my firm and is starting what looks to be a brilliant career with us...(L)ittle did I dream you could be so reckless and so cruel as to do an injury to that lad. It is true that he will continue to be with Hale and Dorr (Welch's law firm). It is, I regret to say, equally true that I fear he shall always bear a scar needlessly inflicted by you. If it were in my power to forgive you for your reckless cruelty I would do so. I like to think that I am a gentle man, but your forgiveness will have to come from someone other than me."

When McCarthy tried to go on the attack once more, Welch stepped in again and famously rebuked:

"Senator, may we not drop this? We know he belonged to the Lawyers Guild...Let us not assassinate this lad further, Senator. You have done enough. Have you no sense of decency, sir? At long last, have you left no sense of decency?"

McCarthy tried to ask Welch another question about Fisher, and Welch cut him off:

"Mr. McCarthy, I will not discuss this with you further. You have sat within six feet of me and could have asked about Fred Fisher. You have brought it out. If there is a God in Heaven it will do neither you nor your cause any good. I will not discuss it further. I will not ask Mr. Cohn any more questions. You, Mr. Chairman, may, if you will, call the next witness."
Pink Sheet, that is.

Two items of note (courtesy of the Pink Sheet) that are urgently important, but getting little attention.

1. Non-Interference

The House health care reform bill passed by the Energy and Commerce Committee directs HHS to negotiate drug prices directly with manufacturers for the Medicare Part D program, but it does not authorize HHS to establish a national formulary.

That leaves the provision vulnerable to being stripped out as the bill proceeds through Congress -on the basis that it may not reduce costs.

The Congressional Budget Office, in past estimates, has consistently concluded that savings generated from direct government price negotiation under Part D would be negligible unless HHS could bring some bargaining leverage to the table.

In a 2007 analysis, then CBO Director (now OMB Director) Peter Orszag wrote: "Negotiation is likely to be effective only if it is accompanied by some sort of pressure on drug manufacturers to secure price concessions."

Specifically, "the authority to establish a formulary, set prices administratively, or take regulatory actions against firms failing to offer price reductions could give the [HHS secretary] the ability to obtain significant discounts."

He added that "in the absence of such authority, the Secretary's ability to issue credible threats or take other actions in an effort to obtain significant discounts would be limited."

2. Comparative Effectiveness

Although it was not introduced during the House Energy and Commerce Committee's markup of the health care reform bill, an amendment prepared by Rep. Donna Christensen, D-V.I., that would create a public-private institute to oversee comparative effectiveness research activities remains in play and could be a part of the final package that is voted on by the House.

Christensen was given the go-ahead to introduce the amendment during the markup, but time constraints kept the amendment, which was filed with the committee, from being introduced for consideration. A staffer for Christensen said the representative has a commitment from Energy and Commerce Chairman Henry Waxman, D-Calif., to work on adding the amendment to the final House bill. The amendment would replace the current language in H.R. 3200 that places coordination of comparative effectiveness research activities within the Agency for Healthcare Research and Quality. The current language creates an independent CER commission to oversee the center, recommend research priorities and conduct stakeholder outreach.

According to a fact sheet on Christensen's amendment, it would create an independent public-private institute governed by a board of directors consisting of the HHS secretary, the directors of AHRQ and the National Institutes of Health, and 20 additional members appointed by GAO representing a broad range of stakeholders, including patients and consumers, physicians, public agencies (CMS and state and federal health programs), private payers, drug and device manufacturers, non-profit health research organizations, quality measurement/decision support organizations and organizations conducting minority health research.

The amendment, co-sponsored by fellow committee Democrat Jay Inslee, Wash., and Republicans Greg Walden, Ore., and Fred Upton, Mich., has a lot in common with the approach that Senate Finance Committee Chairman Max Baucus would like to get into that committee's version of the bill.

Here's AP's Erica Werner taking up the Obama cause to swat away "disinformation" about health care reform:

Support for Obama's approach to health care has dropped in the polls, and the White House sought to address some oft-repeated claims.Among them: Will Medicare benefits be cut? Will government bureaucrats ration care? Will the elderly get progressively less care and then have euthanasia presented as an option?

Sebelius answered: No, no and no.

She said the administration wants to save money in Medicare by eliminating unnecessary procedures and hospital readmissions, among other things, but that there was no desire to eliminate needed benefits. She contended that insurance companies already ration care and that Obama wants to give doctors more control, not less.

As for the euthanasia claim: "Nothing could be less true ... that is just not part of the conversation," Sebelius said.

The rumor has become widespread and seems to stem from a provision in the House bill that would require Medicare to pay for direct consultations with health care professionals. Sebelius noted that no one would be required to use the benefit and said it would help many families. "

Notice any response from people that might have information -- cited and sourced (contra the Sebelius generalities) to the contrary?

Nada.

Nice work, Erica.  Is this on top of your AP salary?

Read article here

When I heard that the other N word (Nazi) was being used or represented by people at town hall meetings it took me about two seconds to realize that those spewing the garbage were none other than LaRouchies who see the rise of fascism behind every government action. See sick site below...

Read it here

Let's be clear: there is nothing Nazi-like about any of the healthcare proposals.  Just writing that, makes me sick.  What is even sicker is how the LaRouche zombies are able to insinuate themselves into rallies, meetings, etc. without being called on it.   Which explains how Borat got made I guess. 

In any event,  it is up to those people and organizations who are genuinely concerned about a government takeover of healthcare to express those opinions with passion, conviction and through democratic action.  And at that same time it might behoove them to call out those who would use the Nazis plan to exterminate the Jews as a metaphor for healthcare reform as beyond the pale of civilized discourse.  


Dobbs Story

  • 08.07.2009
My discussion of Great Britain's National Health Service and NICE (from Thursday night's Lou Dobbs program) can be found here.


CMPI

Center for Medicine in the Public Interest is a nonprofit, non-partisan organization promoting innovative solutions that advance medical progress, reduce health disparities, extend life and make health care more affordable, preventive and patient-centered. CMPI also provides the public, policymakers and the media a reliable source of independent scientific analysis on issues ranging from personalized medicine, food and drug safety, health care reform and comparative effectiveness.

Blog Roll

Alliance for Patient Access Alternative Health Practice
AHRP
Better Health
BigGovHealth
Biotech Blog
BrandweekNRX
CA Medicine man
Cafe Pharma
Campaign for Modern Medicines
Carlat Psychiatry Blog
Clinical Psychology and Psychiatry: A Closer Look
Conservative's Forum
Club For Growth
CNEhealth.org
Diabetes Mine
Disruptive Women
Doctors For Patient Care
Dr. Gov
Drug Channels
DTC Perspectives
eDrugSearch
Envisioning 2.0
EyeOnFDA
FDA Law Blog
Fierce Pharma
fightingdiseases.org
Fresh Air Fund
Furious Seasons
Gooznews
Gel Health News
Hands Off My Health
Health Business Blog
Health Care BS
Health Care for All
Healthy Skepticism
Hooked: Ethics, Medicine, and Pharma
Hugh Hewitt
IgniteBlog
In the Pipeline
In Vivo
Instapundit
Internet Drug News
Jaz'd Healthcare
Jaz'd Pharmaceutical Industry
Jim Edwards' NRx
Kaus Files
KevinMD
Laffer Health Care Report
Little Green Footballs
Med Buzz
Media Research Center
Medrants
More than Medicine
National Review
Neuroethics & Law
Newsbusters
Nurses For Reform
Nurses For Reform Blog
Opinion Journal
Orange Book
PAL
Peter Rost
Pharm Aid
Pharma Blog Review
Pharma Blogsphere
Pharma Marketing Blog
Pharmablogger
Pharmacology Corner
Pharmagossip
Pharmamotion
Pharmalot
Pharmaceutical Business Review
Piper Report
Polipundit
Powerline
Prescription for a Cure
Public Plan Facts
Quackwatch
Real Clear Politics
Remedyhealthcare
Shark Report
Shearlings Got Plowed
StateHouseCall.org
Taking Back America
Terra Sigillata
The Cycle
The Catalyst
The Lonely Conservative
TortsProf
Town Hall
Washington Monthly
World of DTC Marketing
WSJ Health Blog